Stock listing
OSE Stock Price, News, Filings & Events — Ose Immunotherapeutics Sa
Selected listing: OSE · EURONEXT · EUR · FR
This page tracks Ose Immunotherapeutics Sa's OSE:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OSE:EURONEXT. OSE:EURONEXT is the stock-level entry point for investors researching Ose Immunotherapeutics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ose Immunotherapeutics SA is a public company listed on the French market under the ticker OSE. The company has a market capitalization of approximately €82.44 million. Ose Immunotherapeutics focuses on developing innovative immunotherapy solutions for various diseases.
- Ticker
- OSE:EURONEXT
- Asset type
- Stock
- Market cap
- $75.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR
Ose Immunotherapeutics Sa OSE:EURONEXT stock context
This page tracks Ose Immunotherapeutics Sa's OSE:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following OSE:EURONEXT. OSE:EURONEXT is the stock-level entry point for investors researching Ose Immunotherapeutics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ose Immunotherapeutics SA is a public company listed on the French market under the ticker OSE. The company has a market capitalization of approximately €82.44 million. Ose Immunotherapeutics focuses on developing innovative immunotherapy solutions for various diseases.
Latest news from Ose Immunotherapeutics Sa
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for...
September 9, 2026
OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le...
September 8, 2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital
September 6, 2026
OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
August 27, 2026
Informations relatives au nombre total de droits de vote et d’actions composant le capital
August 25, 2026
Research Ose Immunotherapeutics Sa
Ose Immunotherapeutics Sa investor report
Review AI stock analysis and investor report context for OSE:EURONEXT.
Ose Immunotherapeutics Sa company profile
View the public company page for Ose Immunotherapeutics Sa on 6ix.
Ose Immunotherapeutics Sa news
Read company news and market updates connected to Ose Immunotherapeutics Sa.
Ose Immunotherapeutics Sa investor events
Find investor webinars, events, and replay context for Ose Immunotherapeutics Sa.
Alternate listings
0RAD:LSE
GB · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
6OP:GETTEX
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
A14QXP:LSX
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
A14QXP:LS
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
6OP:TRADEGATE
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
OSEP:AQUISEU
GB · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
6OP:MUN
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
ORPOF:OTC
US · USD
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
OSEP:AQUISUK
GB · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
6OP:DUS
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
6OP:FWB
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.
6OP:HAM
DE · EUR
Alternate listing for Ose Immunotherapeutics Sa; the primary context on this page is OSE:EURONEXT.